The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$3.11

Today's change+0.02 +0.65%
Updated March 29 9:51 AM EDT. Delayed by at least 15 minutes.
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$3.11

Today's change+0.02 +0.65%
Updated March 29 9:51 AM EDT. Delayed by at least 15 minutes.

Aralez Pharmaceuticals Inc up $0.02

Aralez Pharmaceuticals Inc is up today by $0.02 or 0.65% to $3.11. Over the last five days, shares have gained 0.97%, but are down 47.38% for the last year to date. Shares have underperformed the S&P TSX by 48.43% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.71
Updated March 29 9:51 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-189.75%

Aralez Pharmaceuticals Inc has a net profit margin of -189.75%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.12%Sector:Industry:

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2014138
Total other revenue--------
Total revenue2014138
Gross profit181096
Total cost of revenue3333
Total operating expense48333046
Selling / general / administrative33252337
Research & development1214
Depreciation / amortization7221
Interest expense (income), net operating--------
Unusual expense (income)4------
Other operating expenses, total1------
Operating income-28-20-17-38
Interest income (expense), net non-operating-50-10
Gain (loss) on sale of assets--------
Other--------
Income before tax-32-20-18-33
Income after tax-31-21-17-34
Income tax, total-10-11
Net income-31-21-17-34
Total adjustments to net income--------
Net income before extra. items-31-21-17-34
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-31-21-17-34
Inc. avail. to common incl. extra. items-31-21-17-34
Diluted net income-31-21-17-34
Dilution adjustment--------
Diluted weighted average shares66656452
Diluted EPS excluding extraordinary itemsvalue per share-0.48-0.32-0.27-0.65
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.43-0.32-0.27-0.65